← Leaderboards
Seongkyu Yoon
University Of Massachusetts Lowell
$1,315,589
Attributed
$1,533,918
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $436.7K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$1,097,260 · 2
NIH$436,658 · 1
By mechanism
U01$1,097,260 · 2
R21$436,658 · 1
Top collaborators
- Mark Alan Blenner1 shared
Most similar at University Of Massachusetts Lowell
Same institution · by research overlap
- Seongkyu Yoon$2,763,530
- Dongming Xie$899,406
- James Sherwood$1,335,555
- Xingwei Wang$583,344
- Hsi-Wu Wong$781,568
Others in their field
Top investigators on “Anti-Viral Response”
- Sharon A Nachman · Johns Hopkins University$74,930,519
- Dan H. Barouch · Fred Hutchinson Cancer Center$31,829,419
- Rafi Ahmed · Emory University$30,387,774
- Jenny P.y. Ting · Univ Of North Carolina Chapel Hill$27,015,158
- Louis J. Picker · Oregon Health And Science University$26,515,591
- Wanda Phipatanakul · Boston Children'S Hospital$25,505,199
Research focus
Anti-Viral ResponseAutomobile DrivingBiogenesisBiomanufacturingBioprocessCandidate Disease GeneCapsidCell Culture TechniquesCell CycleCell Cycle ArrestCell LineCellsClinical TreatmentClinical TrialsConsumptionCostCrispr/Cas TechnologyCytotoxicCytotoxicityDesignDna BiosynthesisDsrna Adenosine DeaminaseEarly PromotersAdenoviruses
Grant awards (7)
Establishing a stable production cell line for recombinant AAV through synthetic dynamic regulation and reducing regulatory and metabolic limitations$436,658
R21 · FY2025 · EB
Data-fusion based platform development of population PKPD modeling and statistical analysis for bioequivalence assessment of long-acting injectable products$199,945
U01 · FY2017 · FD · contact PI
Data-fusion based platform development of population PKPD modeling and statistical analysis for bioequivalence assessment of long-acting injectable products$199,983
U01 · FY2016 · FD · contact PI
Process Modeling and Assessment Tools for Simulation, Risk Management and Design Space Development of Integrated Pharmaceutical Manufacturing Processes$99,251
U01 · FY2016 · FD · contact PI
Data-fusion based platform development of population PKPD modeling and statistical analysis for bioequivalence assessment of long-acting injectable products$199,943
U01 · FY2015 · FD · contact PI
Process Modeling and Assessment Tools for Simulation, Risk Management and Design Space Development of Integrated Pharmaceutical Manufacturing Processes$199,388
U01 · FY2015 · FD · contact PI
Process Modeling and Assessment Tools for Simulation, Risk Management and Design Space Development of Integrated Pharmaceutical Manufacturing Processes$198,750
U01 · FY2014 · FD · contact PI